Insider-Transaktionen

EDGAR

UNIFIRST CORPORATION

Von Direktoren, Führungskräften und 10-%-Eignern auf den SEC-Formularen 3, 4 und 5 gemeldete Transaktionen, aus dem XML jeder Einreichung gelesen. Codes und ihr Wortlaut stammen von der SEC.

Das Formular 4 ist innerhalb von zwei Geschäftstagen nach der Transaktion einzureichen; die jüngsten Geschäfte sind daher möglicherweise noch nicht gemeldet.

Zeitfenster: Transaktionen ab dem 17. Nov. 2025.

Käufe am offenen Markt (Code P)
0 Transaktionen, — Aktien
Verkäufe am offenen Markt (Code S)
2 Transaktionen, 2.592 Aktien
Summe Aktien × Preis je Aktie: 574.915,2

Die Summen addieren die aufgeführten eingereichten Transaktionen; sie zählen das Gemeldete und messen keine Richtung.

1–46 von 46 angezeigt

Insider-Transaktionen, neueste zuerst, wie auf den SEC-Formularen 3, 4 und 5 eingereicht
DatumMeldende PersonCodeErworben oder veräußertAktienPreis je Aktie, wie eingereichtWert (abgeleitet)Aktien danach im BesitzDirekt oder indirektKästchen zu Rule 10b5-1AnmerkungenQuelle
2. Nov. 2026 Eingereicht am 3. Nov. 2026Sintros Steven S Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)2.9070—34.004Direkt (D) Nein
F2
  • F2 Represents restricted stock units that were earned based on the achievement of certain performance criteria and that 50% of such restricted stock units remain subject to vesting on October 31, 2027 and 50% of such restricted stock units remain subject to vesting on October 31, 2028.
Einreichung öffnen 0001628280-26-069623 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026Sintros Steven S Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)6.9630—40.967Direkt (D) Nein
F3, F4, F5
  • F3 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
  • F4 These are annual grants for fiscal 2027.
  • F5 Consists of (i) 22,532 shares of Common Stock owned by the reporting person, (ii) 789 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iii) 1,825 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028, (iii) 1,557 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iv) 3,445 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028, (v) 949 restricted stock units that vest in one remaining annual installment on October 31, 2027, (vi) 2,907 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028 and (vii) 6,963 restricted stock units that vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
Einreichung öffnen 0001628280-26-069623 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026Katz David Martin Officer: Executive VP, Sales/Marketing
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)1.0510—6.558Direkt (D) Nein
F2
  • F2 Represents restricted stock units that were earned based on the achievement of certain performance criteria and which vested.
Einreichung öffnen 0001628280-26-069628 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026Katz David Martin Officer: Executive VP, Sales/Marketing
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)446258,51
115.295,46

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 115295.46.

6.112Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069628 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026Katz David Martin Officer: Executive VP, Sales/Marketing
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)2.5150—8.627Direkt (D) Nein
F3, F4, F5
  • F3 These are annual grants for fiscal 2027.
  • F4 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
  • F5 Consists of (i) 3,128 shares of Common Stock owned by the reporting person, (ii) 355 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iii) 822 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028, (iii) 563 restricted stock units that vest in one remaining annual installment on October 31, 2027 and October 31, 2028, (iv) 1,244 restricted stock units that vest in two equal installments on October 31, 2027 and October 31, 2028, and (v) 2,515 restricted stock units that vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
Einreichung öffnen 0001628280-26-069628 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026Croatti Matthew 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)9680—11.887Direkt (D) Nein
F2, F3, F4
  • F2 These are annual grants for fiscal 2027.
  • F3 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
  • F4 Consists of (i) 9,900 shares of Common Stock owned by the reporting person, (ii) 119 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iii) 274 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028, (iii) 195 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iv) 431 restricted stock units that vest in two equal installments on October 31, 2027 and October 31, 2028 and (v) 968 restricted stock units that vest in three annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
Einreichung öffnen 0001628280-26-069632 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026O'Connor Shane Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)1.3730—10.479Direkt (D) Nein
F2
  • F2 Represents restricted stock units that were earned based on the achievement of certain performance criteria and which vested.
Einreichung öffnen 0001628280-26-069626 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026O'Connor Shane Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)583258,51
150.711,33

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 150711.33.

9.896Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069626 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
2. Nov. 2026 Eingereicht am 3. Nov. 2026O'Connor Shane Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.2890—13.185Direkt (D) Nein
F3, F4, F5
  • F3 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
  • F4 These are annual grants for fiscal 2027.
  • F5 Consists of (i) 6,226 shares of Common Stock owned by the reporting person, (ii) 394 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iii) 913 restricted stock units that vest in two equal annual installments on October 31, 2027 and October 31, 2028, (iii) 736 restricted stock units that vest in one remaining annual installment on October 31, 2027, (iv) 1,627 restricted stock units that vest in two equal installments on October 31, 2027 and October 31, 2028, and (v) 3,289 restricted stock units that vest in three equal annual installments on November 2, 2027, November 2, 2028 and November 2, 2029.
Einreichung öffnen 0001628280-26-069626 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
31. Okt. 2026 Eingereicht am 3. Nov. 2026Sintros Steven S Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)2.885254,84
735.213,4

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 735213.40.

31.097Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069623 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
31. Okt. 2026 Eingereicht am 3. Nov. 2026Katz David Martin Officer: Executive VP, Sales/Marketing
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)954254,84
243.117,36

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 243117.36.

5.507Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069628 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
31. Okt. 2026 Eingereicht am 3. Nov. 2026Croatti Matthew 10% owner
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)324254,84
82.568,16

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 82568.16.

10.919Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069632 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
31. Okt. 2026 Eingereicht am 3. Nov. 2026O'Connor Shane Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)1.161254,84
295.869,24

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 295869.24.

9.106Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001628280-26-069626 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
23. Okt. 2026 Eingereicht am 27. Okt. 2026Croatti Matthew 10% owner
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)1.000119
119.000

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 119000.

11.912Direkt (D) Nein
F1
  • F1 The reported transaction represents the automatic exercise of stock appreciation rights (SARs) immediately prior to their expiration on October 24, 2026. The SARs were automatically exercised in accordance with the terms of the award agreement. There was no sale of shares acquired upon such automatic exercise.
Einreichung öffnen 0001628280-26-067635 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
23. Okt. 2026 Eingereicht am 27. Okt. 2026Croatti Matthew 10% owner
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)669281,29
188.183,01

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 188183.01.

11.243Direkt (D) Nein
F2, F3
  • F2 Includes shares withheld for taxes upon automatic exercise of stock-settled stock appreciation rights.
  • F3 Includes 94 restricted stock units that vest in one remaining annual installment on October 31, 2026, 237 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 411 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 390 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 646 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028 and 9,465 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001628280-26-067635 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
23. Okt. 2026 Eingereicht am 27. Okt. 2026Croatti Matthew 10% owner
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Stock Appreciation Rights — Basiswert Common Stock (1.000) — Ausübungspreis 119
Veräußert (D)1.0000—0Direkt (D) Nein
F1
  • F1 The reported transaction represents the automatic exercise of stock appreciation rights (SARs) immediately prior to their expiration on October 24, 2026. The SARs were automatically exercised in accordance with the terms of the award agreement. There was no sale of shares acquired upon such automatic exercise.
Einreichung öffnen 0001628280-26-067635 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—4.023Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—4.273Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
13. März 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—4.523Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. Feb. 2026 Eingereicht am 18. Feb. 2026Katz David Martin Officer: Executive VP, Sales/Marketing
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)1.464237,54
347.758,56

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 347758.56.

6.461Direkt (D) Ja
F1, F2
  • F1 Represents shares sold pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 14, 2025.
  • F2 Consists of 299 restricted stock units that vest in one remaining annual installment on October 31, 2026, 709 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 1,232 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 1,125 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 1,866 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028 and 1,230 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-26-056419 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. Feb. 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—4.773Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. Feb. 2026 Eingereicht am 10. Feb. 2026Ross William Masters Officer: Executive Vice President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)1.128201,38
227.156,64

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 227156.64.

3.849Direkt (D) Ja
F1, F2
  • F1 Represents shares sold pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 10, 2025.
  • F2 Consists of 224 restricted stock units that vest in one remaining annual installment on October 31, 2026, 552 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 959 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 822 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, and 1,292 restricted stock units that vest in three remaining equal annual installments on October 31, 2026, October 31, 2027, and October 31, 2028.
Einreichung öffnen 0001193125-26-044463 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Feb. 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—5.273Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Feb. 2026 Eingereicht am 21. Apr. 2026Levenstein Cecelia 10% owner
G

Bona fide gift

Common Stock
Veräußert (D)2500—5.023Direkt (D) Nein
F1
  • F1 Represents a pre-planned gift of shares to a charitable organization. The reporting of this transaction was late due to an administrative oversight.
Einreichung öffnen 0001193125-26-167398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
5. Jan. 2026 Eingereicht am 7. Jan. 2026DIFILLIPPO DAVID A Officer: Retired EVP of Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)1.138197,92
225.232,96

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 225232.96.

9.684Direkt (D) Nein
F1
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
Einreichung öffnen 0001193125-26-006372 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Pupkin Sergio A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)5750—1.777Direkt (D) Nein
F1, F2
  • F1 Represents an award of unrestricted Common Stock under the UniFirst Corporation 2023 Stock Option and Incentive Plan.
  • F2 These are annual grants for fiscal 2026.
Einreichung öffnen 0001193125-25-325400 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Pupkin Sergio A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (987) — Ausübungspreis 174.2
Erworben (A)9870—987Direkt (D) Nein
F2, F3
  • F2 These are annual grants for fiscal 2026.
  • F3 This stock appreciation right is exercisable in full on the grant date (12/16/2025) and is required to be settled in stock at the time of exercise. The grant has an expiration date of the earlier of December 16, 2033 or the second anniversary of the date that the grantee ceases to be a member of the Board of Directors.
Einreichung öffnen 0001193125-25-325400 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025McKenney Cecilia K Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)5750—1.230Direkt (D) Nein
F1, F2
  • F1 Represents an award of unrestricted Common Stock under the UniFirst Corporation 2023 Stock Option and Incentive Plan.
  • F2 These are annual grants for fiscal 2026.
Einreichung öffnen 0001193125-25-325392 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025McKenney Cecilia K Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (987) — Ausübungspreis 174.2
Erworben (A)9870—987Direkt (D) Nein
F2, F3
  • F2 These are annual grants for fiscal 2026.
  • F3 This stock appreciation right is exercisable in full on the grant date (12/16/2025) and is required to be settled in stock at the time of exercise. The grant has an expiration date of the earlier of December 16, 2033 or the second anniversary of the date that the grantee ceases to be a member of the Board of Directors.
Einreichung öffnen 0001193125-25-325392 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025O'Connor Shane Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)2.4400—10.267Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of 336 restricted stock units that vest in one remaining annual installment on October 31, 2026, 788 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 1,369 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 1,471 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 2,440 restricted stock units that vest in three equal annual installments on October 3, 2026, October 31, 2027, and October 31, 2028 and 3,863 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-25-325387 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025O'Connor Shane Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (3.500) — Ausübungspreis 174.2
Erworben (A)3.5000—3.500Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325387 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025NOWICKI JOSEPH M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)5750—2.213Direkt (D) Nein
F1, F2
  • F1 Represents an award of unrestricted Common Stock under the UniFirst Corporation 2023 Stock Option and Incentive Plan.
  • F2 These are annual grants for fiscal 2026.
Einreichung öffnen 0001193125-25-325390 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025NOWICKI JOSEPH M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (987) — Ausübungspreis 174.2
Erworben (A)9870—987Direkt (D) Nein
F2, F3
  • F2 These are annual grants for fiscal 2026.
  • F3 This stock appreciation right is exercisable in full on the grant date (12/16/2025) and is required to be settled in stock at the time of exercise. The grant has an expiration date of the earlier of December 16, 2033 or the second anniversary of the date that the grantee ceases to be a member of the Board of Directors.
Einreichung öffnen 0001193125-25-325390 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Rooney Kelly C. Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)3.4450—11.409Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of 1,259 restricted stock units that vest on September 30, 2026, 2,075 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 3,445 restricted stock units that vest in three equal installments on October 31, 2026, October 31, 2027 and October 31, 2028 and 4,630 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-25-325399 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Rooney Kelly C. Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (4.940) — Ausübungspreis 174.2
Erworben (A)4.9400—4.940Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325399 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Iandoli Michael Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (987) — Ausübungspreis 174.2
Erworben (A)9870—987Direkt (D) Nein
F1, F2
  • F1 This stock appreciation right is exercisable in full on the grant date (12/16/2025) and is required to be settled in stock at the time of exercise. The grant has an expiration date of the earlier of December 16, 2033 or the second anniversary of the date that the grantee ceases to be a member of the Board of Directors.
  • F2 This is an annual grant for fiscal 2026.
Einreichung öffnen 0001193125-25-325391 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025CROATTI CYNTHIA Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (987) — Ausübungspreis 174.2
Erworben (A)9870—987Direkt (D) Nein
F1, F2
  • F1 This stock appreciation right is exercisable in full on the grant date (12/16/2025) and is required to be settled in stock at the time of exercise. The grant has an expiration date of the earlier of December 16, 2033 or the second anniversary of the date that the grantee ceases to be a member of the Board of Directors.
  • F2 This is an annual grant for fiscal 2026.
Einreichung öffnen 0001193125-25-325396 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Sintros Steven S Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)5.1670—33.982Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of (i) 18,743 shares of Common Stock owned by the reporting person, (ii) 747 restricted stock units that vest in one remaining annual installment on October 31, 2026, (iii) 1,576 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, (iv) 2,738 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, (v) 3,113 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, (vi) 1,898 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027 and (vii) 5,167 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
Einreichung öffnen 0001193125-25-325398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Sintros Steven S Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (7.410) — Ausübungspreis 174.2
Erworben (A)7.4100—7.410Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325398 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Ross William Masters Officer: Executive Vice President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)1.2920—4.977Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of 224 restricted stock units that vest in one remaining annual installment on October 31, 2026, 552 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 959 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 822 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 1,292 restricted stock units that vest in three remaining equal annual installments on October 31, 2026, October 31, 2027, and October 31, 2028 and 1,128 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-25-325386 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Ross William Masters Officer: Executive Vice President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (1.235) — Ausübungspreis 174.2
Erworben (A)1.2350—1.235Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325386 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Katz David Martin Officer: Executive VP, Sales/Marketing
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)1.8660—7.925Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of 299 restricted stock units that vest in one remaining annual installment on October 31, 2026, 709 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 1,232 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 1,125 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 2,676 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028 and 2,694 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-25-325389 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Katz David Martin Officer: Executive VP, Sales/Marketing
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (2.676) — Ausübungspreis 174.2
Erworben (A)2.6760—2.676Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325389 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Croatti Matthew 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)6460—10.912Direkt (D) Nein
F1, F2, F3
  • F1 Represents restricted stock units granted under the UniFirst Corporation 2023 Stock Option and Incentive Plan (the 2023 Plan). Such restricted stock units vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028.
  • F2 These are annual grants for fiscal 2026.
  • F3 Consists of 94 restricted stock units that vest in one remaining annual installment on October 31, 2026, 237 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, 411 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, 390 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027, 646 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028 and 9,134 shares of Common Stock owned by the reporting person.
Einreichung öffnen 0001193125-25-325394 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. Dez. 2025 Eingereicht am 18. Dez. 2025Croatti Matthew 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Stock Appreciation Right — Basiswert Common Stock ($0.10 par value) (618) — Ausübungspreis 174.2
Erworben (A)6180—618Direkt (D) Nein
F2, F4
  • F2 These are annual grants for fiscal 2026.
  • F4 This stock appreciation right, which was granted under the 2023 Plan, becomes vested and exercisable in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028. This stock appreciation right is required to be settled in stock at the time of exercise.
Einreichung öffnen 0001193125-25-325394 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
19. Nov. 2025 Eingereicht am 21. Nov. 2025Sintros Steven S Director · Officer: President and CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Veräußert (D)287159,85
45.876,95

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 45876.95.

28.815Direkt (D) Nein
F1, F2
  • F1 Represents shares of Common Stock withheld by UniFirst Corporation to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
  • F2 Consists of (i) 18,743 shares of Common Stock owned by the reporting person, (ii) 747 restricted stock units that vest in one remaining annual installment on October 31, 2026, (iii) 1,576 restricted stock units that vest in two remaining equal annual installments on October 31, 2026 and October 31, 2027, (iv) 2,738 restricted stock units that vest in three equal annual installments on October 31, 2026, October 31, 2027 and October 31, 2028, (v) 3,113 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027 and (vi) 1,898 restricted stock units that vest in two equal annual installments on October 31, 2026 and October 31, 2027.
Einreichung öffnen 0001193125-25-290893 Aus dem XML der Einreichung gelesen Diese Zeile anfechten

Institutionelle Halter (Formular 13F)

Quartal zum 2026-09-30: 7.211 Einreichungen gelesen, die jüngste vom 16. Nov. 2026. Vorquartal zum 2026-06-30: 9.150 Einreichungen gelesen.

1–50 von 255 angezeigt

Institutionelle Halter, größte Position zuerst, wie eingereicht
ManagerAktien oder NennbetragWert wie eingereichtDifferenz zum VorquartalQuelle
BlackRock, Inc. Teilweise unter einem anderen Manager gemeldet2.179.286 SH545.954.678 DollarNiedriger um 13.894 Vorquartal: 2.193.180Einreichung öffnen 0002012383-26-003985 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
VANGUARD PORTFOLIO MANAGEMENT LLC 830.346 SH208.018.280 DollarNiedriger um 1.834 Vorquartal: 832.180Einreichung öffnen 0002100121-26-001150 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
DIMENSIONAL FUND ADVISORS LP Teilweise unter einem anderen Manager gemeldet703.965 SH176.361.543 DollarNiedriger um 25.001 Vorquartal: 728.966Einreichung öffnen 0000354204-26-001096 Eingereicht am 4. Nov. 2026 Diese Zeile anfechten
VANGUARD CAPITAL MANAGEMENT LLC 651.039 SH163.098.290 DollarNiedriger um 3.337 Vorquartal: 654.376Einreichung öffnen 0002100119-26-001711 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
STATE STREET CORP Teilweise unter einem anderen Manager gemeldet585.253 SH146.617.582 DollarHöher um 1.168 Vorquartal: 584.085Einreichung öffnen 0000093751-26-000747 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Westchester Capital Management, LLC Teilweise unter einem anderen Manager gemeldet450.744 SH112.920.386 DollarHöher um 163.491 Vorquartal: 287.253Einreichung öffnen 0001512805-26-000013 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
GEODE CAPITAL MANAGEMENT, LLC Teilweise unter einem anderen Manager gemeldet379.833 SH95.173.671 DollarHöher um 3.384 Vorquartal: 376.449Einreichung öffnen 0001214717-26-000012 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
UBS Group AG Teilweise unter einem anderen Manager gemeldet359.437 SH90.046.157 DollarHöher um 216.825 Vorquartal: 142.612Einreichung öffnen 0001610520-26-000121 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Teilweise unter einem anderen Manager gemeldet316.431 SH79.272.356 DollarNiedriger um 29.302 Vorquartal: 345.733Einreichung öffnen 0001398344-26-020056 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
CITIGROUP INC Teilweise unter einem anderen Manager gemeldet308.558 SH77.299.950 DollarHöher um 57.197 Vorquartal: 251.361Einreichung öffnen 0000831001-26-000052 Eingereicht am 4. Nov. 2026 Diese Zeile anfechten
Squarepoint Ops LLC Teilweise unter einem anderen Manager gemeldet259.565 SH65.026.224 DollarHöher um 152.369 Vorquartal: 107.196Einreichung öffnen 0001642575-26-000012 Eingereicht am 9. Nov. 2026 Diese Zeile anfechten
MORGAN STANLEY Teilweise unter einem anderen Manager gemeldet254.914 SH63.861.617 DollarNiedriger um 48.442 Vorquartal: 303.356Einreichung öffnen 0000895421-26-000309 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Magnetar Financial LLC Teilweise unter einem anderen Manager gemeldet174.619 SH43.745.552 DollarUnverändert Vorquartal: 174.619Einreichung öffnen 0001104659-26-126450 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 155.916 SH39.060.076 DollarHöher um 33.636 Vorquartal: 122.280Einreichung öffnen 0001535845-26-000011 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
FIRST TRUST ADVISORS LP 134.723 SH33.750.805 DollarNiedriger um 127.158 Vorquartal: 261.881Einreichung öffnen 0001445546-26-008622 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
NATIXIS ADVISORS, LLC Teilweise unter einem anderen Manager gemeldet124.465 SH31.181 DollarNiedriger um 38.208 Vorquartal: 162.673Einreichung öffnen 0001018331-26-000013 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
JONES FINANCIAL COMPANIES LLLP Teilweise unter einem anderen Manager gemeldet119.544 SH30.972.320 DollarNiedriger um 53.306 Vorquartal: 172.850Einreichung öffnen 0001193125-26-459442 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Bank of New York Mellon Corp Teilweise unter einem anderen Manager gemeldet110.546 SH27.694.209 DollarNiedriger um 5.101 Vorquartal: 115.647Einreichung öffnen 0001390777-26-000121 Eingereicht am 5. Nov. 2026 Diese Zeile anfechten
Centiva Capital, LP 109.127 SH27.338.496 DollarHöher um 73.213 Vorquartal: 35.914Einreichung öffnen 0001172661-26-005016 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Public Sector Pension Investment Board 108.164 SH28.019.884 DollarHöher um 58.249 Vorquartal: 49.915Einreichung öffnen 0001396318-26-000039 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
PRINCIPAL FINANCIAL GROUP INC Teilweise unter einem anderen Manager gemeldet107.382 SH26.901.338 DollarHöher um 12.181 Vorquartal: 95.201Einreichung öffnen 0001126328-26-000225 Eingereicht am 2. Nov. 2026 Diese Zeile anfechten
VANGUARD FIDUCIARY TRUST CO 96.310 SH24.127.581 DollarNiedriger um 203 Vorquartal: 96.513Einreichung öffnen 0000933478-26-000017 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Teilweise unter einem anderen Manager gemeldet94.593 SH23.697.438 DollarHöher um 35.764 Vorquartal: 58.829Einreichung öffnen 0001164508-26-000060 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Verition Fund Management LLC 92.500 SH23.173.100 DollarHöher um 57.500 Vorquartal: 35.000Einreichung öffnen 0001454027-26-000007 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
RENAISSANCE TECHNOLOGIES LLC Teilweise unter einem anderen Manager gemeldet91.700 SH22.972.684 DollarHöher um 64.280 Vorquartal: 27.420Einreichung öffnen 0001037389-26-000062 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Grantham, Mayo, Van Otterloo Co. LLC 83.059 SH20.807.941 DollarNicht in den gelesenen Einreichungen des Vorquartals Einreichung öffnen 0001072613-26-000864 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
JPMORGAN CHASE CO Teilweise unter einem anderen Manager gemeldet79.028 SH20.313.309 DollarNiedriger um 199.825 Vorquartal: 278.853Einreichung öffnen 0000019617-26-000404 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Qube Research Technologies Ltd 78.617 SH19.695.131 DollarNiedriger um 46.355 Vorquartal: 124.972Einreichung öffnen 0001729829-26-000018 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Centiva Capital, LP Option: Put 71.500 SH17.912.180 DollarNicht in den gelesenen Einreichungen des Vorquartals Einreichung öffnen 0001172661-26-005016 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
FMR LLC Teilweise unter einem anderen Manager gemeldet64.738 SH16.218.161 DollarHöher um 39.690 Vorquartal: 25.048Einreichung öffnen 0000315066-26-002964 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
Invesco Ltd. Teilweise unter einem anderen Manager gemeldet62.710 SH15.710.110 DollarHöher um 4.058 Vorquartal: 58.652Einreichung öffnen 0000914208-26-000462 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Nuveen, LLC Teilweise unter einem anderen Manager gemeldet61.852 SH15.495.163 DollarNiedriger um 14.095 Vorquartal: 75.947Einreichung öffnen 0000930413-26-003284 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
PSquared Asset Management AG 59.265 SH14.847.068 DollarHöher um 36.900 Vorquartal: 22.365Einreichung öffnen 0000945621-26-001387 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Fenimore Asset Management Inc 44.147 SH11.059.706 DollarHöher um 40 Vorquartal: 44.107Einreichung öffnen 0001376474-26-000635 Eingereicht am 8. Okt. 2026 Diese Zeile anfechten
TimesSquare Capital Management, LLC Teilweise unter einem anderen Manager gemeldet40.996 SH10.270.318 DollarNiedriger um 23.910 Vorquartal: 64.906Einreichung öffnen 0001193125-26-444305 Eingereicht am 3. Nov. 2026 Diese Zeile anfechten
RHUMBLINE ADVISERS 38.906 SH9.746.707 DollarNiedriger um 1.288 Vorquartal: 40.194Einreichung öffnen 0001115418-26-000015 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
Tweedy, Browne Co LLC 34.714 SH8.696.551 DollarNiedriger um 66.839 Vorquartal: 101.553Einreichung öffnen 0000732905-26-000001 Eingereicht am 4. Nov. 2026 Diese Zeile anfechten
NINE MASTS CAPITAL Ltd 29.899 SH7.490.297 DollarHöher um 16.829 Vorquartal: 13.070Einreichung öffnen 0001569356-26-000007 Eingereicht am 9. Nov. 2026 Diese Zeile anfechten
OMERS ADMINISTRATION Corp 29.712 SH7.443.450 DollarNicht in den gelesenen Einreichungen des Vorquartals Einreichung öffnen 0001062993-26-005989 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Swiss National Bank 27.900 SH6.989.508 DollarHöher um 200 Vorquartal: 27.700Einreichung öffnen 0001582202-26-000008 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
BLAIR WILLIAM CO/IL 27.893 SH6.987.879 DollarHöher um 1.042 Vorquartal: 26.851Einreichung öffnen 0001104659-26-124894 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
GABELLI FUNDS LLC 26.600 SH6.663.832 DollarHöher um 4.500 Vorquartal: 22.100Einreichung öffnen 0001140361-26-043450 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
GABELLI Co INVESTMENT ADVISERS, INC. 26.299 SH6.588.425 DollarHöher um 3.299 Vorquartal: 23.000Einreichung öffnen 0001140361-26-043448 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Creative Planning Teilweise unter einem anderen Manager gemeldet25.598 SH6.412.811 DollarHöher um 1.552 Vorquartal: 24.046Einreichung öffnen 0001540235-26-000006 Eingereicht am 2. Nov. 2026 Diese Zeile anfechten
TEACHER RETIREMENT SYSTEM OF TEXAS 25.481 SH6.383.500 DollarHöher um 23.860 Vorquartal: 1.621Einreichung öffnen 0000796848-26-000015 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
BNP PARIBAS FINANCIAL MARKETS Teilweise unter einem anderen Manager gemeldet22.878 SH5.731.397 DollarHöher um 8.896 Vorquartal: 13.982Einreichung öffnen 0001166588-26-000012 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Quantinno Capital Management LP 22.274 SH5.580.282 DollarHöher um 741 Vorquartal: 21.533Einreichung öffnen 0001759654-26-000011 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Hudson Bay Capital Management LP 20.932 SH5.243.884 DollarNiedriger um 4.068 Vorquartal: 25.000Einreichung öffnen 0001393825-26-000083 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Alberta Investment Management Corp 20.000 SH5.010.400 DollarUnverändert Vorquartal: 20.000Einreichung öffnen 0001123292-26-001506 Eingereicht am 9. Nov. 2026 Diese Zeile anfechten
STIFEL FINANCIAL CORP Teilweise unter einem anderen Manager gemeldet18.535 SH4.643.414 DollarNiedriger um 7.128 Vorquartal: 25.663Einreichung öffnen 0000720672-26-000017 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Manager des Vorquartals ohne gelesene Einreichung für das neueste

Sie haben möglicherweise nur noch nicht eingereicht: Das Fehlen in den gelesenen Einreichungen des neuesten Quartals bedeutet nicht, dass die Position verkauft wurde.

  • LONDON CO OF VIRGINIA 740.213 SH
  • MILLENNIUM MANAGEMENT LLC 510.016 SH
  • Balyasny Asset Management L.P. 277.520 SH
  • ALPINE ASSOCIATES MANAGEMENT INC. 235.364 SH
  • Sixth Street Partners Management Company, L.P. 221.334 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 221.334 SH
  • CITADEL ADVISORS LLC 202.054 SH
  • NORTHERN TRUST CORP 188.721 SH
  • TIG Advisors, LLC 183.161 SH
  • Birnam Oak Advisors, LP 171.148 SH
  • BANK OF AMERICA CORP /DE/ 158.466 SH
  • AQR Arbitrage LLC 147.098 SH
  • GOLDMAN SACHS GROUP INC 125.246 SH
  • BRANDES INVESTMENT PARTNERS, LP 112.591 SH
  • ENVESTNET ASSET MANAGEMENT INC 90.344 SH
  • Melqart Asset Management (UK) Ltd 84.865 SH
  • Empyrean Capital Partners, LP 81.000 SH
  • WELLS FARGO COMPANY/MN 76.663 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 75.512 SH
  • CANYON CAPITAL ADVISORS LLC 75.000 SH
  • Quarry LP 64.088 SH
  • Capula Management Ltd 55.000 SH
  • LMR Partners LLP 53.726 SH
  • Allianz Asset Management GmbH 53.470 SH
  • River Road Asset Management, LLC 47.547 SH
  • Schonfeld Strategic Advisors LLC 40.000 SH
  • Schonfeld Strategic Advisors LLC 38.125 SH
  • Sand Grove Capital Management LLP 36.266 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 35.767 SH
  • ExodusPoint Capital Management, LP 32.804 SH
  • SIRIOS CAPITAL MANAGEMENT L P 32.802 SH
  • Legal General Group Plc 32.161 SH
  • HOTCHKIS WILEY CAPITAL MANAGEMENT LLC 26.621 SH
  • Man Group plc 25.690 SH
  • AMERIPRISE FINANCIAL INC 25.224 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 21.845 SH
  • THIRD AVENUE MANAGEMENT LLC 20.802 SH
  • Jupiter Topco LLC 20.162 SH
  • ROYAL BANK OF CANADA 19.960 SH
  • ALLIANCEBERNSTEIN L.P. 18.041 SH
  • PRUDENTIAL FINANCIAL INC 15.065 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 14.600 SH
  • XTX Topco Ltd 14.524 SH
  • Governors Lane LP 14.055 SH
  • DDD Partners, LLC 14.036 SH
  • Corient Private Wealth LP 13.875 SH
  • Polar Asset Management Partners Inc. 13.255 SH
  • Point72 Asset Management, L.P. 13.213 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 13.138 SH
  • STATE OF WISCONSIN INVESTMENT BOARD 11.799 SH
  • Das Formular 13F umfasst nur Long-Positionen in Wertpapieren nach Section 13(f): keine Short-Positionen und keine Wertpapiere außerhalb dieser Liste.
  • Ein Manager, der für das neueste Quartal noch nicht eingereicht hat, fehlt und steht nicht bei null; die Frist beträgt bis zu 45 Tage nach Quartalsende.
  • Eine Differenz ist der Unterschied zwischen zwei Quartalsstichtagen, keine Transaktion.
  • Eine unter einem anderen Manager gemeldete Position kann auch in dessen Einreichung erscheinen; die Zeilen werden nicht addiert.
  • Positionen, die die Wertpapierliste diesem Unternehmen nicht oder nur mehrdeutig zuordnen kann, werden nicht angezeigt.

5-%-Halter (Schedule 13D und 13G)

Hier werden im strukturierten SEC-Format (ab Ende 2024) eingereichte Schedules gelesen. Frühere sind Freitext und werden nicht gelesen.

5-%-Halter, jüngstes Ereignis zuerst, wie eingereicht
HalterProzent der GattungGehaltene AktienEreignisdatumFormularQuelle
Dimensional Fund Advisors LP Common Stock4.8703.965,0009/30/2026 Eingereicht am 8. Okt. 2026SCHEDULE 13G/AÄnderung 1Einreichung öffnen 0000354204-26-001045 Diese Zeile anfechten
The London Company Class A Common Stock5.09740.213,0006/30/2026 Eingereicht am 14. Aug. 2026SCHEDULE 13G/AÄnderung 4Einreichung öffnen 0001398344-26-014472 Diese Zeile anfechten
Vanguard Capital Management Common Stock5.24762.17903/31/2026 Eingereicht am 30. Apr. 2026SCHEDULE 13GEinreichung öffnen 0002100119-26-001206 Diese Zeile anfechten
Vanguard Portfolio Management Common Stock5.68826.09903/31/2026 Eingereicht am 29. Apr. 2026SCHEDULE 13GEinreichung öffnen 0002100121-26-000806 Diese Zeile anfechten
River Road Asset Management, LLC Common Stock3.9571.761,0003/16/2026 Eingereicht am 17. März 2026SCHEDULE 13D/AÄnderung 3Einreichung öffnen 0001341401-26-000008 Diese Zeile anfechten
The Vanguard Group Common Stock0003/13/2026 Eingereicht am 27. März 2026SCHEDULE 13G/AÄnderung 14Einreichung öffnen 0000102909-26-002558 Diese Zeile anfechten
Cintas Corp Common Stock18.73.374.968,0003/10/2026 Eingereicht am 16. März 2026SCHEDULE 13DEinreichung öffnen 0000950103-26-003802 Diese Zeile anfechten
River Road Asset Management, LLC Common Stock5.0733.118,0002/25/2026 Eingereicht am 26. Feb. 2026SCHEDULE 13D/AÄnderung 2Einreichung öffnen 0001341401-26-000006 Diese Zeile anfechten
River Road Asset Management, LLC Common Stock6.1881.303,0011/25/2025 Eingereicht am 25. Nov. 2025SCHEDULE 13D/AÄnderung 1Einreichung öffnen 0001341401-25-000041 Diese Zeile anfechten
River Road Asset Management, LLC Common Stock6.1881.303,0011/14/2025 Eingereicht am 17. Nov. 2025SCHEDULE 13DEinreichung öffnen 0001341401-25-000039 Diese Zeile anfechten
BlackRock, Inc. Common Stock14.32.149.15306/30/2025 Eingereicht am 17. Juli 2025SCHEDULE 13G/AÄnderung 16Einreichung öffnen 0002052113-25-003273 Diese Zeile anfechten

Der Prozentsatz bezieht sich auf die in der Einreichung genannte Gattung, wie vom Halter angegeben. Gruppenmitglieder melden jeweils die Aktien der Gruppe; die Zeilen werden daher nicht addiert.

Was gelesen wurde

2.131.613 Einreichungen gelesen, vom 14. Juni 2004 bis 16. Nov. 2026: Formulare 3, 3/A, 4, 4/A, 5, 5/A.

Jahre können unvollständig sein, solange das Archiv noch gelesen wird. Ein Jahr mit wenigen Einreichungen hier besagt nicht, dass wenige gemacht wurden.

Gelesene Einreichungen nach Einreichungsjahr
EinreichungsjahrGelesene Einreichungen
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
202254.718
2023199.811
2024209.823
2025235.520
2026254.802

Einreichungen aus der Zeit vor der XML-Pflicht der SEC sind aufgeführt, aber nicht ausgelesen.

Zurück zu UNIFIRST CORPORATION